Literature DB >> 19797735

A primer on strategies for prevention and control of seasonal and pandemic influenza.

Scott Santibañez1, Anthony E Fiore, Toby L Merlin, Stephen Redd.   

Abstract

The United States has made considerable progress in pandemic preparedness. Limited attention, however, has been given to the challenges faced by populations that will be at increased risk of the consequences of the pandemic, including challenges caused by societal, economic, and health-related factors. This supplement to the American Journal of Public Health focuses on the challenges faced by at-risk and vulnerable populations in preparing for and responding to an influenza pandemic. Here, we provide background information for subsequent articles throughout the supplement. We summarize (1) seasonal influenza epidemiology, transmission, clinical illness, diagnosis, vaccines, and antiviral medications; (2) H5N1 avian influenza; and (3) pandemic influenza vaccines, antiviral medications, and nonpharmaceutical interventions.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19797735      PMCID: PMC4504386          DOI: 10.2105/AJPH.2009.164848

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  64 in total

1.  Disease mitigation measures in the control of pandemic influenza.

Authors:  Thomas V Inglesby; Jennifer B Nuzzo; Tara O'Toole; D A Henderson
Journal:  Biosecur Bioterror       Date:  2006

2.  Antigen sparing and cross-reactive immunity with an adjuvanted rH5N1 prototype pandemic influenza vaccine: a randomised controlled trial.

Authors:  Isabel Leroux-Roels; Astrid Borkowski; Thomas Vanwolleghem; Mamadou Dramé; Frédéric Clement; Eliane Hons; Jeanne-Marie Devaster; Geert Leroux-Roels
Journal:  Lancet       Date:  2007-08-18       Impact factor: 79.321

3.  Nonpharmaceutical interventions implemented by US cities during the 1918-1919 influenza pandemic.

Authors:  Howard Markel; Harvey B Lipman; J Alexander Navarro; Alexandra Sloan; Joseph R Michalsen; Alexandra Minna Stern; Martin S Cetron
Journal:  JAMA       Date:  2007-08-08       Impact factor: 56.272

4.  Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

Authors:  F G Hayden; A D Osterhaus; J J Treanor; D M Fleming; F Y Aoki; K G Nicholson; A M Bohnen; H M Hirst; O Keene; K Wightman
Journal:  N Engl J Med       Date:  1997-09-25       Impact factor: 91.245

5.  Investigation of avian influenza (H5N1) outbreak in humans--Thailand, 2004.

Authors:  Darin Areechokchai; C Jiraphongsa; Y Laosiritaworn; W Hanshaoworakul; M O'Reilly
Journal:  MMWR Suppl       Date:  2006-04-28

6.  Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.

Authors:  A S Monto; D M Fleming; D Henry; R de Groot; M Makela; T Klein; M Elliott; O N Keene; C Y Man
Journal:  J Infect Dis       Date:  1999-08       Impact factor: 5.226

Review 7.  Mass vaccination for annual and pandemic influenza.

Authors:  B Schwartz; P Wortley
Journal:  Curr Top Microbiol Immunol       Date:  2006       Impact factor: 4.291

8.  Influenza vaccination coverage among children aged 6-23 months--United States, 2006-07 influenza season.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2008-09-26       Impact factor: 17.586

9.  Two clusters of human infection with influenza A/H5N1 virus in the Republic of Azerbaijan, February-March 2006.

Authors:  A Gilsdorf; N Boxall; V Gasimov; I Agayev; F Mammadzade; P Ursu; E Gasimov; C Brown; S Mardel; D Jankovic; G Pimentel; I Amir Ayoub; E Maher Labib Elassal; C Salvi; D Legros; C Pessoa da Silva; A Hay; R Andraghetti; G Rodier; B Ganter
Journal:  Euro Surveill       Date:  2006

10.  Risk factors for human infection with avian influenza A H5N1, Vietnam, 2004.

Authors:  Pham Ngoc Dinh; Hoang Thuy Long; Nguyen Thi Kim Tien; Nguyen Tran Hien; Le Thi Quynh Mai; Le Hong Phong; Le Van Tuan; Hoang Van Tan; Nguyen Binh Nguyen; Phan Van Tu; Nguyen Thi Minh Phuong
Journal:  Emerg Infect Dis       Date:  2006-12       Impact factor: 6.883

View more
  9 in total

1.  Protection of racial/ethnic minority populations during an influenza pandemic.

Authors:  Sonja S Hutchins; Kevin Fiscella; Robert S Levine; Danielle C Ompad; Marian McDonald
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

2.  Pandemic influenza and jail facilities and populations.

Authors:  Laura M Maruschak; William J Sabol; R H Potter; Laurie C Reid; Emily W Cramer
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

3.  Protecting vulnerable populations from pandemic influenza in the United States: a strategic imperative.

Authors:  Sonja S Hutchins; Benedict I Truman; Toby L Merlin; Stephen C Redd
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

Review 4.  The influenza pandemic of 2009: lessons and implications.

Authors:  Paul Shapshak; Francesco Chiappelli; Charurut Somboonwit; John Sinnott
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

5.  Extensive geographical mixing of 2009 human H1N1 influenza A virus in a single university community.

Authors:  Edward C Holmes; Elodie Ghedin; Rebecca A Halpin; Timothy B Stockwell; Xing-Quan Zhang; Regina Fleming; Richard Davey; Constance A Benson; Sanjay Mehta; Randy Taplitz; Yu-Tseung Liu; Kimberly C Brouwer; David E Wentworth; Xudong Lin; Robert T Schooley
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

6.  A neighborhood susceptibility index for planning of local physical interventions in response to pandemic influenza outbreaks.

Authors:  Toomas Timpka; Henrik Eriksson; Magnus Strömgren; Olle Eriksson; Joakim Ekberg; Anders Grimvall; James Nyce; Elin Gursky; Einar Holm
Journal:  AMIA Annu Symp Proc       Date:  2010-11-13

7.  Pandemic influenza: implications for programs controlling for HIV infection, tuberculosis, and chronic viral hepatitis.

Authors:  James D Heffelfinger; Pragna Patel; John T Brooks; Helene Calvet; Charles L Daley; Hazel D Dean; Brian R Edlin; Kathleen F Gensheimer; John Jereb; Charlotte K Kent; Jeffrey L Lennox; Janice K Louie; Ruth Lynfield; Philip J Peters; Lauretta Pinckney; Philip Spradling; Andrew C Voetsch; Anthony Fiore
Journal:  Am J Public Health       Date:  2009-10       Impact factor: 9.308

Review 8.  Naturally Occurring Terpenes: A Promising Class of Organic Molecules to Address Influenza Pandemics.

Authors:  Suhad A A Al-Salihi; Fabrizio Alberti
Journal:  Nat Prod Bioprospect       Date:  2021-05-03

9.  A geographic analysis of population density thresholds in the influenza pandemic of 1918-19.

Authors:  Siddharth Chandra; Eva Kassens-Noor; Goran Kuljanin; Joshua Vertalka
Journal:  Int J Health Geogr       Date:  2013-02-20       Impact factor: 3.918

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.